| Ytd | -14.05% | |
| 1y | 211.76% |
| Open | 3.18 | Prev Close | 3.18 | Low | 3.18 | High | 3.18 | Mkt Cap | 661.15M |
| Vol | 0.00 | Avg Vol | 14.97M | EPS | -0.06 | P/E | -53.00 | Forward P/E | 11.20 |
| Beta | 0.95 | Short Ratio | 5.70 | Inst. Own | 66.34% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 3.15 | 200-d Avg | 3.09 | 1yr Est | 7.51 |
ESPR News
For the tens of millions of Americans who cannot push their LDL cholesterol (trivially known as "
Stockholders of Esperion Therapeutics NASDAQ: ESPR approved the company's merger agreement with Esse
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti,
– Bempedoic Acid Lowered LDL-C and Was Well Tolerated in Children Aged 6-17 Years – – A Secondary An
ANN ARBOR, Mich., May 14, 2026 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that on M
Esperion shares jump nearly 44% in a month. The primary catalyst was Archimed's agreement to acquire
– Presentations Examine Findings From the Pediatric Phase 2 Study, As Well As Factors Associated Wi
NEW YORK, May 05, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde &
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti,
US stocks were mixed on Friday, with Dow Jones down 0.1%. Veeva Systems Inc (NYSE: VEEV) rose 11.6%,
NEW YORK, May 01, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & A
MILWAUKEE, May 1, 2026 /PRNewswire/ -- Ademi LLP is investigating Esperion (NASDAQ: ESPR) for possib
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale
Investment firm Archimed will take Esperion Therapeutics private for up to $1.1 billion, the compan
Esperion shareholders to receive $3. 16 per share in cash at closing, plus the right to participate
ANN ARBOR, Mich., April 23, 2026 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced it will
Esperion Therapeutics (NASDAQ: ESPR) outlined its commercial progress and strategic priorities at Ne
Esperion Therapeutics (ESPR) reported earnings 30 days ago. What's next for the stock?
JPMorgan Chase and Co. raised its stake in Esperion Therapeutics, Inc. (NASDAQ: ESPR) by 68.4% in th
NEW YORK and ANN ARBOR, Mich., April 02, 2026 (GLOBE NEWSWIRE) -- Athyrium Capital Management, LP an
– Enbumyst, First and Only FDA-Approved Nasal Spray Loop Diuretic Now Integrated into Esperion's Ca
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings
Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is estimated to report earnings for it
Companies Reporting Before The Bell • BP (NYSE:BP) is estimated to report quarterly earnings at $2.
Companies Reporting Before The Bell • Ferrari (NYSE:RACE) is expected to report quarterly earnin
Companies Reporting Before The Bell • Kiniksa Pharmaceuticals (NASDAQ:KNSA) is projected to repo
Stocks That Hit 52-Week Lows On Monday
Stocks That Hit 52-Week Highs On Wednesday
Stocks That Hit 52-Week Highs On Friday